- Home
- ABCB vs OGN Comparison
ABCB vs OGN Comparison
Compare ABCB & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABCB
- OGN
- Stock Information
- Founded
- ABCB 1971
- OGN 1923
- Country
- ABCB United States
- OGN United States
- Employees
- ABCB N/A
- OGN N/A
- Industry
- ABCB Major Banks
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- ABCB Finance
- OGN Health Care
- Exchange
- ABCB Nasdaq
- OGN Nasdaq
- Market Cap
- ABCB 4.0B
- OGN 4.0B
- IPO Year
- ABCB N/A
- OGN N/A
- Fundamental
- Price
- ABCB $57.12
- OGN $14.51
- Analyst Decision
- ABCB Buy
- OGN Hold
- Analyst Count
- ABCB 7
- OGN 5
- Target Price
- ABCB $70.00
- OGN $20.80
- AVG Volume (30 Days)
- ABCB 521.6K
- OGN 4.1M
- Earning Date
- ABCB 04-24-2025
- OGN 05-01-2025
- Dividend Yield
- ABCB 1.40%
- OGN 7.72%
- EPS Growth
- ABCB 33.42
- OGN N/A
- EPS
- ABCB 5.19
- OGN 3.33
- Revenue
- ABCB $1,082,451,000.00
- OGN $6,403,000,000.00
- Revenue This Year
- ABCB $10.31
- OGN N/A
- Revenue Next Year
- ABCB $8.63
- OGN $1.52
- P/E Ratio
- ABCB $11.00
- OGN $4.36
- Revenue Growth
- ABCB 15.51
- OGN 2.23
- 52 Week Low
- ABCB $44.23
- OGN $13.87
- 52 Week High
- ABCB $74.56
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- ABCB 36.54
- OGN 40.58
- Support Level
- ABCB $56.61
- OGN $14.81
- Resistance Level
- ABCB $60.34
- OGN $14.81
- Average True Range (ATR)
- ABCB 1.31
- OGN 0.47
- MACD
- ABCB 0.26
- OGN -0.09
- Stochastic Oscillator
- ABCB 35.86
- OGN 11.44
About ABCB Ameris Bancorp
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.
About OGN Organon & Co.
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.